INTRODUCTION
Infectious diseases are one of the most deadly diseases in the world 1 . Recently, the number of bacterial and fungal infections has rised dangereously 2 . Antibiotics and antifungals are the most important drug groups used in the treatment of bacterial and fungal infections. With the discovery of antibiotics, these drugs have begun to be used as main drugs in the treatment of infections. But over time, bacteria have begun to develop resistance because of frequent use and misuse. An uncontrolled increase in resistance of pathogenic microorganisms has wasted health resources [3] [4] [5] . This resistance to antimicrobial agents has shown that there is an urgent need for new treatment strategies and new antimicrobial drug discovery studies.
Heterocyclic chemistry was discovered in the early 1800s. Heterocyclic members have an important area in organic chemistry because they have broad range of pharmacological effects 6 . Among them, oxadiazole is one of the prominent aromatic ring containing oxygen and nitrogen atoms. Due to its electronic and charge-transport properties it can be easily connected to various functional groups 7 . In addition, oxadiazoles have been extensively studied over recent years due to their different biological activities. This five member heterocyclic ring plays an important role in medicinal chemistrywhich exists in new molecules as pharmacophore groups 8, 9 . Different classes of oxadiazoles have broad range of pharmacological activities such as antimalarial, anticonvulsant, analgesic, antimicrobial, antimycobacterial, antitumor, vasodilator, cytotoxic, hypolipidemic, antiproliferative, antifungal [10] [11] [12] [13] [14] [15] [16] [17] . Some of prescribed agents possessing oxadiazole ring are antimicrobial furamizole 6 , antiretroviral agent raltegravir and antihypertensive agent nesapidil 18 ( Figure 1 ).
Figure 1. Some oxadiazole possessing drugs
Additionally, 1,3,4-oxadiazoles are good bioisosteres of amide and ester groups that exhibit different biological activities by making strong hydrogen bonds with different receptors 10, 11 . On the other hand, 1,3,4-oxadizoles can react with the nucleophilic centers of microbial cells by reacting with the presence of the -N = C-O toxophoric group 18 .
There are several methods in the literature for the synthesis of 1,3,4-oxadiazoles.
Furamizole Raltegravir
Nesadipil By using acid hydrazides, phosphorus oxychloride, sulfuric acid, and thionyl chloride, the oxadiazole ring was obtained in several steps 14, 15, 19 . However, the method of synthesis of 1,3,4-oxadiazoles by reaction of carboxylic acid and acid hydrazides is not a highly preferred method because it is expensive and requires a long time 20 .
In this study, we have synthesized seven novel compounds combining 5-(4-chlorobenzyl)-1,3,4-oxadiazol-2-thiol and 2-chloro-N-(2-benzothiazolyl) acetamide derivatives. The antimicrobial activity of the synthesized compounds was investigated against different microorganisms compared with standard drugs chloramphenicol and ketoconazole.
METHODOLOGY

Chemistry
All chemicals were purchased from Sigma-Aldrich Chemical Co (Sigma-Aldrich Corp., St. Louis, MO, USA) and Merck Chemicals (Merck KGaA, Darmstadt, Germany). All melting points (m.p.) were determined by MP90 digital melting point apparatus (Mettler Toledo, Ohio, USA) and were uncorrected. All reactions were monitored by thin-layer chromatography (TLC) using Silica Gel 60 F254 TLC plates (Merck KGaA, Darmstadt, Germany). Spectroscopic data were recorded with the following instruments: IR, Shimadzu Affinity 1S spectrophotometer (Shimadzu, Tokyo, Japan); NMR, Agilent 300 MHz NMR spectrometer (Agilent technologies, California, USA), in DMSO-d 6 , using TMS as internal standard; M+1 peaks were determined by Shimadzu 8040 LC/MS/MS system (Shimadzu, Tokyo, Japan). Elemental analyses were performed on a Leco 932 CHNS analyzer (Leco, Michigan, USA).
Synthesis of ethyl 4-chlorophenyl acetate (1)
4-Chlorophenyl acetic acid (0.40 mol) was refluxed with excess ethanol for 12h catalyzed with H 2 SO 4 . After TLC check, the solvent was evaporated under reduced pressure. The residue was dissolved in ethyl acetate, washed with salty water and dried with sodium sulfate. Ethyl acetate was evaporated under reduced pressure to gain ester compound (1).
Synthesis of 2-(4-chlorophenyl)acetohydrazide (2)
Ethyl 4-chlorophenyl acetate (0.25 mol) was dissolved in ethanol (150 ml). Hydrazine hydrate (0.50 mol) added and the mixture stirred in room temperature for 2h. After completion of reaction, the solvent was separated by filtration to acquire hydrazide compound 2.
Synthesis of 5-(4-chlorobenzyl)-1,3,4-oxadiazole-2-thiol (3)
2-(4-Chlorophenyl)acetohydrazide (0.20 mol) was dissolved in ethanol (250 ml). 0. 24 mol of potassium hydroxide was dissolved in ethanol (100 mL)and added to the mixture. Secondly, carbon disulfide (0.60 mol) was added to the mixture, and it was refluxed for 5 hours. After this period, cold water and dilute HCl were added to the reaction mixture to gain product 3.
Synthesis of 2-[(5-(4-chlorobenzyl)-1,3,4-oxadiazol-2-yl)thio]-N-(6-substituted benzothiazol-2-yl)acetamidederivatives (4a-g)
5-(4-Chlorobenzyl)-1,3,4-oxadiazole-2-thiol (10 mmol) was dissolved in acetone (50 mL), potassium carbonate (12 mmol) and appropriate 2-chloro-N-(2-benzothiazolyl)acetamide derivatives were added to this solution and stirred for 12h in room temperature. After TLC screening, the solvent was evaporated under reduced pressure then water was added to wash the resulting solid and the mixture was filtered, dried and recrystallized from ethanol to give final compounds 4a-g.
2-[(5-(4-Chlorobenzyl)-1,3,4-oxadiazol-2-yl)thio]-N-(benzothiazol-2-yl)acetamide (4a)
Yield: 69 %. M.p. 231°C. 
2-[(5-(4-Chlorobenzyl)-1,3,4-oxadiazol-2-yl)thio]-N-(6-methylbenzothiazol-2-yl)acetamide(4b)
Yield: 72 %. M.p. 244°C. 5-(4-Chlorobenzyl)-1,3,4-oxadiazol-2-yl)thio]-N-(6-methoxybenzothiazol-2-yl) 
2-[(
2-[(5-(4-Chlorobenzyl)-1,3,4-oxadiazol-2-yl)thio]-N-(6-ethoxybenzothiazol-2-yl)acetamide (4d)
Yield: 68 %. M.p. 233°C. 
2-[(5-(4-Chlorobenzyl)-1,3,4-oxadiazol-2-yl)thio]-N-(6-chlorobenzothiazol-2-yl)acetamide (4e)
Yield
2-[(5-(4-Chlorobenzyl)-1,3,4-oxadiazol-2-yl)thio]-N-(6-florobenzothiazol-2-yl)acetamide (4f)
Yield: 69 %. M.p. 241°C. 
2-[(5-(4-Chlorobenzyl)-1,3,4-oxadiazol-2-yl)thio]-N-(6-nitrobenzothiazol-2-yl)acetamide (4g)
Yield: 73 %. M.p. 245°C. The lowest concentration that completely inhibited growth of the microorganism was defined as the minimum inhibitor concentration (MIC). MIC was screened and the results were compared to chloramphenicol and ketoconazole as positive controls. Each experiment was replicated twice.
RESULTS AND DISCUSSION
Chemistry
In this study, we have synthesized 2-[(5-(4-chlorobenzyl)-1,3,4-oxadiazol-2-yl) thio]-N-(6-substituted benzothiazol-2-yl)acetamide derivatives (4a-g) with four step synthetic procedure as shown Scheme 1. In the first step, compound 1 was synthesized by reacting 4-chlorophenyl acetic acid with H 2 SO 4 in ethanol at reflux conditions. In the second step, compound 2 was synthesized by reacting 4-chlorophenyl acetate with hydrazine hydrate in ethanol at the room temperature. In the third step, compound 3 was synthesized by reacting 2-(4-chlorophenyl)acetohydrazide with potassium hydroxide and carbon disulfide in ethanol at the reflux conditions. In the last step, compounds 4a-g were synthesized by reacting 5-(4-chlorobenzyl)-1,3,4-oxadiazol-2-thiol with 2-chloro-N-(2-benzothiazolyl)acetamide derivatives in acetone at room temperature. The gained raw products were crystallized from ethanol. Table 1 . MIC values of the compounds were found between 50-100 µg/ml and they were identified between 12.5-50 µg/ml for reference drugs. Compound 4a showed antimicrobial activity against all microorganisms at 50µg/ml concentration. Compounds 4b, 4c, 4e and 4g exhibited activity against E. coli ATCC 35218 and P. aeruginosa at 100 µg/ml and against other bacteria at 50 µg/ml. MIC values were calculated against P. aeruginosa as 100 µg/ml for compound 4d and against E. coli ATCC 35218 as 100 µg/ml for 4f. Additionally, all compounds showed potency at the higher concentration against six bacteria E.coli ATCC 25922, E. coli ATCC 35218, E. faecalis ATCC 51299, E. faecalis ATCC 29212, S. aureus, K.pneumoniae. 4a and 4f exhibited same potency against P. aeruginosa compared with chloramphenicol. All compounds showed lower activity against C. albicans than ketoconazole and they exhibited same potency against three fungal microorganisms C. krusei, C. glabrata, C. parapsilosis compared reference. 
